← Open Payments lookup

KO GENG LIUO: Open Payments

NPI 1841683406 · SANTA ANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,264 in 62 payments from 11 companies in 2025. Trend: 2023 $457 · 2024 $563 · 2025 $1,264

Food & beverage: $1,264
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.18$346
Teva Pharmaceuticals USA, Inc.14$262
ABBVIE INC.7$151
Vanda Pharmaceuticals Inc.4$100
Neurocrine BioSciences, Inc.4$88
Alkermes, Inc.3$71
Takeda Pharmaceuticals U.S.A., Inc.4$65
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$59
Janssen Pharmaceuticals, Inc2$54
E.R. Squibb & Sons, L.L.C.2$45

Products named: REXULTI, AUSTEDO XR, VRAYLAR, UZEDY, FANAPT, INGREZZA, ARISTADA, TRINTELLIX.

Industry payments across CA — which companies pay providers there.